JAZZ
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
$32
About Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Details
Daily high
$234.29
Daily low
$227.05
Price at open
--
52 Week High
$266.38
52 Week Low
$128.80
Market cap
15.2B
Dividend yield
-
Volume
10
Avg. volume
897,505
P/E ratio
79.59
Jazz Pharmaceuticals plc - Ordinary Shares News
Details
Daily high
$234.29
Daily low
$227.05
Price at open
--
52 Week High
$266.38
52 Week Low
$128.80
Market cap
15.2B
Dividend yield
-
Volume
10
Avg. volume
897,505
P/E ratio
79.59